Fig. 25From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s diseaseThe predicted binding mode of compound C17 in the active site of BuChE [46]Back to article page